Slower stomach emptying and your tablets
Tirzepatide slows stomach emptying, especially when you first start treatment. This can change how quickly a tablet reaches your bloodstream. A later peak level does not mean you lose the whole dose or need more tablets.
The UK product information expects no routine dose changes for most oral medicines. The label does recommend monitoring for medicines with a narrow therapeutic index, such as warfarin or digoxin, particularly when you start tirzepatide and after each increase. Medicines you need to work fast may also need a look.
Precautions for the contraceptive pill
If you take an oral contraceptive, follow UK advice: add a barrier method or use a suitable non-oral method for four weeks after starting and after each increase. Taking the pill at a different hour has not been shown to replace this.
Vomiting and heavy diarrhoea can also reduce the pill's protection on their own. The same symptoms affect other medicines too, and the right response depends on the drug and the timing. Ask a pharmacist before you repeat a tablet you may have vomited up.
Insulin and sulphonylureas need a hypo plan
Taking tirzepatide with insulin or a sulphonylurea can raise the risk of low blood glucose. Your clinician may adjust those medicines and recommend monitoring. Do not cut down or stop insulin on your own because your appetite has dropped.
Metformin and SGLT2 inhibitors raise different points. The label allows you to keep taking them in the relevant combinations. An illness that dehydrates you may call for sick-day advice specific to each medicine. Discuss your everyday treatment and your plan for a vomiting illness as two separate topics.
Supplements and other weight-loss products count too
Tell your prescriber about vitamins, iron, herbal products, laxatives, anti-sickness medicines and anything sold for appetite or fat loss. A product can worsen symptoms or add risk even without a documented direct chemical interaction with tirzepatide.
Do not combine Mounjaro with another GLP-1 medicine or a second tirzepatide product on your own. Different brand names do not guarantee different ingredients. Stacking overlapping treatments is no supported answer to a plateau. Any switch needs a clear plan for when to stop one and start the other.
How to ask for a medicines review
Bring the name, dose and timing of everything you use, plus the reason for each prescription. Include recent changes and any episodes of vomiting, diarrhoea, dizziness or low glucose. A pharmacist will often spot problems a list of brand names alone would miss.
Ask whether your monitoring should change after the next dose increase. Ask whom to contact if illness stops you eating normally or taking tablets. Do not stop a needed treatment because an interaction checker shows a warning without context. Leave with a specific plan: what to continue, what to monitor and which symptoms need urgent advice.
Sources
Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.
- Mounjaro UK Summary of Product Characteristics, updated September 2026 medicines.org.uk
- Mounjaro UK patient information leaflet medicines.org.uk
- NHS Specialist Pharmacy Service: GLP-1 considerations and interactions sps.nhs.uk
- NHS: low blood sugar nhs.uk
- MHRA: GLP-1 medicines, what you need to know gov.uk
Spotted something out of date? Report a mistake.